作者: Patrice M Milos , Albert B Seymour
DOI: 10.1186/1479-7364-1-6-444
关键词:
摘要: The rapid pace of genomic science advancements, including the completion human genome sequence, extensive cataloguing genetic variation and acceleration technologies to assess such variation, combined with clinical programmes rich phenotypic data, serve as foundation for design execution pharmacogenomic studies which have an impact on pharmaceutical pipeline from early discovery through marketplace. authors discuss required infrastructure support provide insight into strategies practical application influence decision making in setting. Further, pharmacogenomics is currently affecting patient care oncology area highlighted evident